Buy ADVAGRAF 0.5MG Tacrolimus Prolonged Release Hard Capsules

ADVAGRAF 0.5MG contains tacrolimus in prolonged-release capsules, used for organ transplant maintenance. This extended-release formulation provides steady immunosuppression. Ideal for long-term therapy with ambient storage. A trusted option for transplant patients.

Strength

0.5mg

Pack Size

50s

Storage

Ambient

Manufacturer / TM Owner

Astellas Ireland Co. Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Tacrolimus prolonged-release capsules like ADVAGRAF 0.5MG are primarily used to prevent organ rejection after kidney or liver transplants. They belong to a class of medications called immunosuppressants, which help the body accept the new organ. This medication is not a cure but supports long-term transplant success. Always taken as prescribed by a healthcare provider.

Side Effects

ADVAGRAF 0.5MG works gradually to reduce immune system activity, helping prevent organ rejection. Users may notice improved transplant function over time. Some people experience mild digestive effects early in treatment. Effects vary by individual and should be monitored by a medical professional.

Precautions & Warnings

Store ADVAGRAF 0.5MG at room temperature, away from moisture and heat. Keep out of reach of children and pets. Do not open or crush capsules unless directed. Regular blood tests are important to monitor drug levels and organ function. Always follow your doctor’s storage and handling instructions.

Avoid Interactions

ADVAGRAF 0.5MG may interact with certain antibiotics, antifungals, and herbal supplements. Grapefruit and grapefruit juice can affect how the medication works. Some heart and blood pressure medications may also interact. Always inform your healthcare provider about all medications and supplements you take.

References

Frequently Asked Questions

ADVAGRAF 0.5MG is used to prevent organ rejection after kidney or liver transplants by suppressing the immune system.

Store at room temperature, away from moisture and heat, and keep out of reach of children.

Do not open or crush the capsule unless instructed by your doctor; swallow it whole.

Yes, grapefruit and grapefruit juice may affect how the medication works in your body.

It is a prolonged-release immunosuppressant used long-term to help prevent organ rejection.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.